Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 2507-2510, June 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sumantran, V. N.
Right arrow Articles by Wicha, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sumantran, V. N.
Right arrow Articles by Wicha, M. S.

Overexpression of Bcl-xS Sensitizes MCF-7 Cells to Chemotherapy-induced Apoptosis1

Venil N. Sumantran, Mark W. Ealovega, Gabriel Nuñez, Michael F. Clarke and Max S. Wicha2

Departments of Internal Medicine [V. N. S., M. W. E., M. F. C., M. S. W.] and Pathology [G. N.], University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109-0724

Resistance to apoptosis plays an important role in tumors that are refractory to chemotherapy. We report that Bcl-xL, which functions like Bcl-2 to inhibit apoptosis, is highly expressed in MCF-7 human breast carcinoma cells. We used Bcl-xS, a dominant negative inhibitor of Bcl-2 and Bcl-xL, to demonstrate the role of these genes in modulating chemotherapy-induced apoptosis. Bcl-xS overexpressed in MCF-7 cells by stable transfection does not affect viability by itself but induces a marked increase in chemosensitivity to VP-16 or taxol. Using an ELISA assay which quantitates DNA damage, we demonstrate that this sensitization is due to apoptosis, suggesting the therapeutic utility of targeting this pathway.

1 This research was supported by NIH Grants CA-61777 and CA-64556, and American Cancer Society Grant BE-161C. G. N. is supported by NIH Research Career Development Award K04 CA64421-01.

2 To whom requests for reprints should be addressed, at Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, 102 Observatory Street, Ann Arbor, MI 48109-0724.

Received 3/ 1/95. Accepted 4/21/95.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Revil, J. Pelletier, J. Toutant, A. Cloutier, and B. Chabot
Heterogeneous Nuclear Ribonucleoprotein K Represses the Production of Pro-apoptotic Bcl-xS Splice Isoform
J. Biol. Chem., August 7, 2009; 284(32): 21458 - 21467.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. J. Suzuki, H. Nagase, C. M. Wong, S. V. Kumar, V. Jain, A.-M. Park, and R. M. Day
Regulation of Bcl-xL Expression in Lung Vascular Smooth Muscle
Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 678 - 687.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
M. J. Worsham, K. M. Chen, N. Tiwari, G. Pals, J. P. Schouten, S. Sethi, and M. S. Benninger
Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg, April 1, 2006; 132(4): 409 - 415.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Garneau, T. Revil, J.-F. Fisette, and B. Chabot
Heterogeneous Nuclear Ribonucleoprotein F/H Proteins Modulate the Alternative Splicing of the Apoptotic Mediator Bcl-x
J. Biol. Chem., June 17, 2005; 280(24): 22641 - 22650.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. Marshall, H. Chen, D. Yang, M. Figueira, K. B. Bouker, Y. Ling, M. Lippman, S. R. Frankel, and D. F. Hayes
A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors
Ann. Onc., August 1, 2004; 15(8): 1274 - 1283.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Burchert, D. Cai, L. C. Hofbauer, M. K. R. Samuelsson, E. P. Slater, J. Duyster, M. Ritter, A. Hochhaus, R. Muller, M. Eilers, et al.
Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2
Blood, May 1, 2004; 103(9): 3480 - 3489.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. Simstein, M. Burow, A. Parker, C. Weldon, and B. Beckman
Apoptosis, Chemoresistance, and Breast Cancer: Insights From the MCF-7 Cell Model System
Experimental Biology and Medicine, October 1, 2003; 228(9): 995 - 1003.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. R. Mercatante, J. L. Mohler, and R. Kole
Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents
J. Biol. Chem., December 13, 2002; 277(51): 49374 - 49382.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. G. Ferreira, M. Epping, F. A. E. Kruyt, and G. Giaccone
Apoptosis: Target of Cancer Therapy
Clin. Cancer Res., July 1, 2002; 8(7): 2024 - 2034.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. E. Chalfant, K. Rathman, R. L. Pinkerman, R. E. Wood, L. M. Obeid, B. Ogretmen, and Y. A. Hannun
De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells. DEPENDENCE ON PROTEIN PHOSPHATASE-1
J. Biol. Chem., April 5, 2002; 277(15): 12587 - 12595.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Sale, R. Sung, P. Shen, K. Yu, Y. Wang, G. E. Duran, J.-H. Kim, T. Fojo, P. J. Oefner, and B. I. Sikic
Conservation of the Class I {beta}-Tubulin Gene in Human Populations and Lack of Mutations in Lung Cancers and Paclitaxel-resistant Ovarian Cancers
Mol. Cancer Ther., January 1, 2002; 1(3): 215 - 225.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. E. Luker, C. M. Pica, R. D. Schreiber, and D. Piwnica-Worms
Overexpression of IRF9 Confers Resistance to Antimicrotubule Agents in Breast Cancer Cells
Cancer Res., September 1, 2001; 61(17): 6540 - 6547.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
V. N. Sumantran, D. S. Lee, V. V. Baker, S. Murray, M. Strawderman, and M. S. Wicha
A Bcl-xS Adenovirus Demonstrates Therapeutic Efficacy in an Ascites Model of Human Breast Cancer
Reproductive Sciences, May 1, 2000; 7(3): 184 - 189.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. N. Sumantran, R. Zhang, D. S. Lee, and M. S. Wicha
Differential Regulation of Apoptosis in Normal versus Transformed Mammary Epithelium by Lutein and Retinoic Acid
Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 257 - 263.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
S. W. Lowe and A. W. Lin
Apoptosis in cancer
Carcinogenesis, March 1, 2000; 21(3): 485 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Mortensen, J. Skouv, D. M. Hougaard, and L.-I. Larsson
Endogenous Endothelial Cell Nitric-oxide Synthase Modulates Apoptosis in Cultured Breast Cancer Cells and Is Transcriptionally Regulated by p53
J. Biol. Chem., December 31, 1999; 274(53): 37679 - 37684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Dong, W. Wang, F. Wang, M. Stoner, J. C. Reed, M. Harigai, I. Samudio, M. P. Kladde, C. Vyhlidal, and S. Safe
Mechanisms of Transcriptional Activation of bcl-2 Gene Expression by 17beta -Estradiol in Breast Cancer Cells
J. Biol. Chem., November 5, 1999; 274(45): 32099 - 32107.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. S. Chang, A. Kelekar, M. H. Harris, J. E. Harlan, S. W. Fesik, and C. B. Thompson
The BH3 Domain of Bcl-xS Is Required for Inhibition of the Antiapoptotic Function of Bcl-xL
Mol. Cell. Biol., October 1, 1999; 19(10): 6673 - 6681.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. Dumontet and B. I. Sikic
Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death
J. Clin. Oncol., March 1, 1999; 17(3): 1061 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. M. Coco Martin, A. Balkenende, T. Verschoor, F. Lallemand, and R. Michalides
Cyclin D1 Overexpression Enhances Radiation-induced Apoptosis and Radiosensitivity in a Breast Tumor Cell Line
Cancer Res., March 1, 1999; 59(5): 1134 - 1140.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Pecci, A. Scholz, D. Pelster, and M. Beato
Progestins Prevent Apoptosis in a Rat Endometrial Cell Line and Increase the Ratio of bcl-XL to bcl-XS
J. Biol. Chem., May 2, 1997; 272(18): 11791 - 11798.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. A. Hannun
Apoptosis and the Dilemma of Cancer Chemotherapy
Blood, March 15, 1997; 89(6): 1845 - 1853.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Czubayko, A. M. Schulte, G. J. Berchem, and A. Wellstein
Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin
PNAS, December 10, 1996; 93(25): 14753 - 14758.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. R. Mercatante, C. D. Bortner, J. A. Cidlowski, and R. Kole
Modification of Alternative Splicing of Bcl-x Pre-mRNA in Prostate and Breast Cancer Cells. ANALYSIS OF APOPTOSIS AND CELL DEATH
J. Biol. Chem., May 4, 2001; 276(19): 16411 - 16417.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.